IFNA1 and systemic lupus erythematosus: Moreover, the present study suggests that IFN-α plays a mechanistic role in the immunomodulating effects of hCDR1 in SLE since the addition of recombinant IFN-α diminished the effects of hCDR1 on cytokine expression in PBMC of SLE patients (Figure 5).